In a First, Immune Checkpoint Inhibitors Show Effectiveness in Metastatic Colorectal Cancer  

In trial after clinical trial, metastatic colorectal cancer has been largely undeterred by immune checkpoint inhibitors.  Although these drugs have shown effectiveness in Hodgkin lymphoma, lung cancer, bladder cancer, kidney cancer, and nearly a dozen other malignancies, their track record against colorectal cancer has been lackluster, particularly for patients with the most common subtype of … Read more

Lynch Syndrome Center Helps Family Stay Vigilant — and Grow 

The first time Jay Reese was diagnosed with colon cancer, he didn’t tell his preschool-aged children. After it came back decades later, he told them immediately — and then suggested they take action.   Jay underwent genetic testing after his 2012 colon cancer recurrence which revealed he had Lynch syndrome, an inherited genetic condition which carries … Read more

Sidney Farber Scholar Pursues Innovative Treatments for Leukemia 

Physician-scientist Franziska Wachter, MD, came to Dana-Farber 10 years ago as a postdoctoral fellow with a vision. In the clinic, she cares for children with hard-to-treat cases of acute myeloid leukemia (AML). In the laboratory, her eyes are on the molecular drivers of the disease.   “I try to connect the two roles as much as … Read more

Are There Cancers of Red Blood Cells and Blood Platelets? 

While hematological cancers like leukemia, lymphoma, and multiple myeloma involve white blood cells, other, rarer hematologic malignancies affect red blood cells and platelets. These include polycythemia vera, in which the bone marrow produces too many red blood cells, and essential thrombocythemia, in which platelets levels are abnormally high. Both are chronic diseases that can usually … Read more

Bladder Cancer Treatment Advances: What’s the Latest? 

Bladder cancer treatment is advancing, with several approved immunotherapy options, an approved gene therapy, and an approach to cell therapy planned for testing in clinical trials at Dana-Farber.  What is bladder cancer?  The most common form of bladder cancer is urothelial carcinoma, in which the urothelial cells that line the bladder and urinary tract begin … Read more

Prostate Cancer Risk and Screening: Five Things You Need to Know  

Prostate cancer is the most common cancer diagnosed in men. When found early, before it has spread, patients can do extremely well.  However, prostate cancer risks vary due to genetics, health care access, socioeconomics, and environmental exposures. Some groups have higher risks and worse outcomes. For example:  The best way to improve your chances of … Read more

Breast Cancer Disparities: What Is Dana-Farber Doing to Address Them?  

Overall survival of breast cancer has improved for everyone in the U.S. in recent years, but the pace isn’t the same for all groups of people. Some groups still experience dramatic disparities.   For example, according to the American Cancer Society:  Dana-Farber wants to close these gaps so that everyone benefits equally from high-quality care and … Read more

Dana-Farber’s Focus on Equity in Breast Cancer Clinical Research 

Clinical trials assess new medicines to ensure they are safe and effective and to find out which patients they are most likely to benefit.   However, clinical trials often enroll few people of color for a constellation of reasons related to historical marginalization of certain groups. Systemic marginalization can result in lower levels of income, fewer … Read more

Science Behind Targeted Drug for Pediatric Brain Cancer Has Dana-Farber Roots 

Dana-Farber researcher Charles Stiles, PhD, remembers the call. It was 2008 and a colleague phoned from a conference to deliver the news. Two separate research teams had discovered a genetic driver for the most common of childhood brain tumors called pediatric low-grade glioma. The problem of finding a genetic target to improve treatment for this … Read more

Improving Everything: Movement and Exercise Helped Breast Cancer Patient Restore Her Mobility and More

 When Sandra Noack returned home from a visit to Bogota, Colombia, to visit her family, there was a letter waiting for her. It was a leaflet sent via the Massachusetts Department of Public Health describing a clinical trial at Dana-Farber Cancer Institute for Latina and Hispanic breast cancer survivors.  The trial didn’t involve any medicine. … Read more

Simone Ledward-Boseman Shares Advice with Dana-Farber Caregivers and Patients 

Simone Ledward-Boseman has many roles: She’s a writer, artist, and singer. And for some time, she was a caregiver to her late husband, Chadwick Boseman, the actor known for playing Black Panther and groundbreaking figures like James Brown and Jackie Robinson. These days, Ledward-Boseman has added more titles to her list: activist and advocate.  “I’m … Read more

Cervical Cancer Disparities: What to Know and Tips for Prevention 

Cervical cancer is caused by a virus called HPV (human papilloma virus) that is spread through sexual contact. For many people, the virus is cleared by the immune system. But if it isn’t, it can develop into cancer.   The virus can be detected through HPV screening that inspects a sample of cervical tissue for the … Read more